InsidersTradesSigma
Hansa Biopharma AB: management transactions · Finland · FIN-FSA
FI:hansa-biopharma-abSE0002148817FI·FIN-FSAMcap 2.9Bn€Healthcare
Browse the full management transaction log of Hansa Biopharma AB, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Hansa Biopharma AB has logged 5 insider filings. Market capitalisation: €2.9bn. The latest transaction was filed on 11 March 2026 (Purchase). Among the most active insiders: RENÉE AGUIAR LUCANDER. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
€2m
4 ops.
Buy Volume
€19,037
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
28.84 €
Analyst consensus
7 analystsStrong buy
35.00 €Target 75.00 €(+160%)103.00 €
Income statement
Revenue222.3 M€
Gross profit138.7 M€62% margin
Net income−534.1 M€-240.3% margin
Valuation
PER (forward)-7.2x
Beta1.50
Balance sheet & cash
Market cap2.88 Bn€
Total debt938.7 M€
Free Cash Flow−549.2 M€
Profitability & ownership
ROA-38.2%
% insiders9.8%
% institutions47.5%
Last declaration on 11 March 2026
Declarations0 total
No declarations found
0 of 0 declarations